The FDA Is Watching - Webinar CD/Transcript
The FDA Is Watching: What Twitter, Tradeshows and TV Have in Common
The FDA’s focus on promotional activities is no longer limited to magazine and TV ads.
Now they're looking at websites, Twitter, journal articles, TV appearances, Facebook — and more.
It’s a brave new world for drug- and devicemakers. Are you ready for it?
There’s more: FDA officials have been seen walking the floors at medical meetings and industry trade shows, apparently on the lookout for improper promotional materials.
They’re poking around, checking the signage in your booth … carefully watching the promotional video messages you're showing … and listening to the physicians and other healthcare professionals you’ve paid to offer expertise or provide demos.
It's not much of a leap to begin to think that the FDA has probably created an electronic beehive of monitors and data to keep track of promotional activities of the drug and device markets.
Well, tell that to the drug company CEO who got slapped with a warning letter just days after making an appearance on CNBC. The warning letter said that comments the executive made on the television show constituted promotional speech and resulted in a misbranding of the company's product.
Many industry insiders have been shocked at the speed , detailed nature and the fact that the letter sent to the CEO was a warning letter rather than the typical untitled letter.
And all indications are that the FDA will continue this full-court press now — and in the future.
How can you and your organization defend yourselves?
Order the FDAnews webinar CD and transcript of The FDA Is Watching: What Twitter, Tradeshows and TV Have in Common. In this invaluable session, you will:
- Explore some of the more unique and challenging promotional pitfalls you may encounter in 2014
- Discuss activities the FDA may now consider promotional that they traditionally did not
- Find out how the FDA’s recent enforcement actions should lead you to reconsider and possibly modify your current approach to policies and training for both promotional and corporate and media communications
- Review checklists that can help you vet your own trade show promotions – so your employees are ready and prepared if and when the FDA visits your booth
- Learn guidelines (and receive checklists) that will help you improve communications with the media and media-type outlets, including social media
- Get new tools for developing a strong proactive legal strategy that will better protect your company by setting standards and safeguards to ensure claims are legally defensible
- Find out how to conduct a “gap analysis” of your current compliance program, plus learn ways to train personnel so they understand what claims are legal and safe to make, identify when claims can become dangerous, and know the difference
Take action now to get a clear understanding of what the FDA expects, the best legal strategy to respond to FDA accusations, and the most effective way to develop a preventive plan in-house. Order your webinar CD and transcript today.